Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
Nearly all those treated in a recent trial were cured.
The high cost of hepatitis C treatment in the U.S. is about to see a major shift to lower prices of the major leading hepatitis C treatments
This Ukrainian woman didn’t let outdated hepatitis C treatment or limited access to them, prevent her from getting necessary medical care.
Genotype 3 of hepatitis C virus is typically difficult to treat.
A photographer helps his mom get cured of hep C after reading Hep magazine.
More than 125,000 veterans will have received lifesaving cures by October 2018.
With many hepatitis C treatments on the market today, patients may ask which hepatitis C treatment is right for me? What’s the difference?
The annual scientific meeting on liver health revealed exciting new findings concerning the battle against the hep C epidemic.
In a recent study of more than 600 HIV-positive adults, 93 percent were cured of hep C.
Sovaldi (sofosbuvir) plus the new hep C drug ravidasvir cured 97 percent of those with a range of genotypes in a recent study.
Among those without cirrhosis, treating for an additional four weeks is unnecessary.
A recent study of Dutch clinicians found that they generally did a good job of preventing drug-drug interactions.
Ending the epidemic is going to require addressing the fact that certain individuals are at high risk of reinfection after a cure.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.